Massachusetts Senator Bruce Tarr joined CutisPharma today as it announced the opening of a Research and Development center to house the company’s expanding R&D team. The new center will provide office and laboratory space to facilitate the company’s aggressive plans for developing products for FDA approval under its wholly owned subsidiary, RM Therapeutics.

ribbon-cutting

ribbon-cutting